Live Quote · NASDAQNVCTHealthcare· Biotechnology

Nuvectis Pharma, Inc.

$19.39▼ 2.27%($-0.45)
MKT CAP $666.80MNEXT EARNINGS Feb 10, 2027
50%
Bullish
TickerSpark Score
49/100
▌ Weak
67
Valuation
20
Profitability
15
Growth
84
Health
60
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NVCT research report →

Analyst Price Target
$37.33+92.5% vs. today

Range $33 – $40

Analyst RatingBuy
3 Buy0 Hold0 Sell

Price Chart

+229.76% · this period
$28.53$17.17$5.81Nov 20May 26Nov 20
52-Week Range58% of range
Low
$5.77
Current
$19.39
High
$29.28

AI analysis · Last refreshed November 15, 2026 · Live quote · Not investment advice